Speaker illustration

Doctor Bernhard Ohnewein

Paracelsus Private Medical University, Salzburg (Austria)

Effects of angiotensin receptor-neprilysin inhibitors (ARNIs) on the glucose and fat metabolism biomarkers leptin and fructosamin

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Neprilysin inhibition: news and nuggets


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb